• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Incyte Corporation (INCY)

    -NasdaqGS
    77.05 Up 1.47(1.94%) Dec 18, 4:00PM EST
    |After Hours : 77.05 0.00 (0.00%) Dec 18, 6:19PM EST
    Add to Portfolio
    Prev Close:75.58
    Open:76.36
    Bid:76.00 x 100
    Ask:80.10 x 600
    1y Target Est:81.54
    Beta:0.17
    Earnings Date:Feb 10 - Feb 16 (Est.)
    Day's Range:75.88 - 77.85
    52wk Range:40.30 - 80.78
    Volume:1,173,524
    Avg Vol (3m):1,332,850
    Market Cap:13.02B
    P/E (ttm):N/A
    EPS (ttm):-0.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for INCY

    Comparison

    Symbol% ChgMkt Cap
    INCYUp 1.94%13.02B
    AMGNUp 3.06%128.16B
    CELGUp 3.24%93.03B
    RHHBYUp 2.39%250.73B

    Key Statistics

    Forward P/E (1 yr):350.23
    P/S (ttm):26.35
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.13
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-7.06

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary small molecule drugs primarily for oncology and inflammation. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback